Related references
Note: Only part of the references are listed.The PD-1/PD-L pathway in rheumatic diseases
Shuo Zhang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2021)
Roles of BTLA in Immunity and Immune Disorders
Zhaochen Ning et al.
FRONTIERS IN IMMUNOLOGY (2021)
BTLA Expression and Function Are Impaired on SLE B Cells
Annika Wiedemann et al.
FRONTIERS IN IMMUNOLOGY (2021)
The etiology of rheumatoid arthritis
Hans Ulrich Scherer et al.
JOURNAL OF AUTOIMMUNITY (2020)
Expression patterns of CD28 and CTLA-4 in early, chronic, and untreated rheumatoid arthritis
Mariel Garcia-Chagollan et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
The relationship between TIGIT+ regulatory T cells and autoimmune disease
Darren J. Lee
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Revisiting the PD-1 pathway
Nikolaos Patsoukis et al.
SCIENCE ADVANCES (2020)
Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases
Chuan Huang et al.
JOURNAL OF AUTOIMMUNITY (2019)
What did we learn from CTLA-4 insufficiency on the human immune system?
Noriko Mitsuiki et al.
IMMUNOLOGICAL REVIEWS (2019)
BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection
Xueping Yu et al.
FRONTIERS IN IMMUNOLOGY (2019)
The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation
Wenwen Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
Kotaro Matsuda et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression
Yanxia Guo et al.
PLOS ONE (2018)
Inhibitory Receptor Expression on T Cells as a Marker of Disease Activity and Target to Regulate Effector Cellular Responses in Rheumatoid Arthritis
Luisina I. Onofrio et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Smoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid Arthritis
Caroline Wasen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development
Hooi-Yeen Yap et al.
CELLS (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis
Caroline Wasen et al.
JOURNAL OF AUTOIMMUNITY (2017)
Pathogenetic insights from the treatment of rheumatoid arthritis
Iain B. McInnes et al.
LANCET (2017)
Are programmed cell death 1 gene polymorphisms correlated with susceptibility to rheumatoid arthritis? A meta-analysis
Yuming Zou et al.
MEDICINE (2017)
The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis (vol 11, e0155345, 2016)
Bin Yang et al.
PLOS ONE (2017)
VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes
Sabrina Ceeraz et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Checkpoint Inhibitors: Applications for Autoimmunity
Anna S. Tocheva et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2017)
Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis
Shinichiro Nakachi et al.
ARTHRITIS RESEARCH & THERAPY (2017)
TIGIT overexpression diminishes the function of CD4 T cells and ameliorates the severity of rheumatoid arthritis in mouse models
Weigong Zhao et al.
EXPERIMENTAL CELL RESEARCH (2016)
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity
Qianxia Zhang et al.
IMMUNITY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM
Yuwen Zhu et al.
SCIENCE ADVANCES (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy
Bernice Lo et al.
SCIENCE (2015)
An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction
Chen Zhu et al.
NATURE COMMUNICATIONS (2015)
Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
Theodore Kouo et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Inhibitory receptors beyond T cell exhaustion
Silvia A. Fuertes Marraco et al.
FRONTIERS IN IMMUNOLOGY (2015)
Expression of TIM-3 on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid of rheumatoid arthritis
Shufeng Li et al.
APMIS (2014)
LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses
Feng Xu et al.
CANCER RESEARCH (2014)
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
Nicole Joller et al.
IMMUNITY (2014)
Expression of Programmed Death-1 (PD-1) on CD4+and CD8+T cells in Rheumatoid Arthritis
Shufeng Li et al.
INFLAMMATION (2014)
Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell-mediated immunity
Dallas B. Flies et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
Christopher J. Chan et al.
NATURE IMMUNOLOGY (2014)
Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis
Helene Asnagli et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy
Bronwen R. Burton et al.
NATURE COMMUNICATIONS (2014)
A Promoter Region Polymorphism in PDCD-1 Gene Is Associated with Risk of Rheumatoid Arthritis in the Han Chinese Population of Southeastern China
CuiPing Liu et al.
INTERNATIONAL JOURNAL OF GENOMICS (2014)
Impact of the CTLA-4/CD28 axis on the processes of joint inflammation in rheumatoid arthritis
Dezsoe Koermendy et al.
ARTHRITIS AND RHEUMATISM (2013)
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
Jennifer Pieper et al.
BMC IMMUNOLOGY (2013)
Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells
S. Liu et al.
CELL DEATH AND DIFFERENTIATION (2013)
The Influence of T Cell Ig Mucin-3 Signaling on Central Nervous System Autoimmune Disease Is Determined by the Effector Function of the Pathogenic T Cells
Sarah Y. Lee et al.
JOURNAL OF IMMUNOLOGY (2013)
The Expression and Anatomical Distribution of BTLA and Its Ligand HVEM in Rheumatoid Synovium
Yongjun Shang et al.
INFLAMMATION (2012)
Underexpression of TIM-3 and Blunted Galectin-9-Induced Apoptosis of CD4+T Cells in Rheumatoid Arthritis
Jaejoon Lee et al.
INFLAMMATION (2012)
Increased production of circulating soluble co-stimulatory molecules CTLA-4, CD28 and CD80 in patients with rheumatoid arthritis
Ju Cao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation
Omar S. Qureshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
Tadashi Yokosuka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
Shigeki Chiba et al.
NATURE IMMUNOLOGY (2012)
Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort
Mohammed Z. Cader et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
A Functional Polymorphism in B and T Lymphocyte Attenuator Is Associated with Susceptibility to Rheumatoid Arthritis
Mie Oki et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
T-cell immunoglobulin and mucin domain 3 genetic polymorphisms are associated with rheumatoid arthritis independent of a shared epitope status
Yeong Wook Song et al.
HUMAN IMMUNOLOGY (2011)
Th17 Cells Express Interleukin-10 Receptor and Are Controlled by Foxp3- and Foxp3+ Regulatory CD4+ T Cells in an Interleukin-10-Dependent Manner
Samuel Huber et al.
IMMUNITY (2011)
The-1541 C>T and+4259 G>T of TIM-3 polymorphisms are associated with rheumatoid arthritis susceptibility in a Chinese Hui population
J. Xu et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2011)
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Li Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: A Monoclonal Antibody Specific for the Programmed Death-1 Homolog Prevents Graft-versus-Host Disease in Mouse Models
Dallas B. Flies et al.
JOURNAL OF IMMUNOLOGY (2011)
Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
Judong Lee et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis
J. Lee et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2011)
Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
Omar S. Qureshi et al.
SCIENCE (2011)
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Lucy S. K. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Slow Down and Survive: Enigmatic Immunoregulation by BTLA and HVEM
Theresa L. Murphy et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Role of Th17 Cells in Human Autoimmune Arthritis
Jan Leipe et al.
ARTHRITIS AND RHEUMATISM (2010)
Association of the CD28/CTLA4/ICOS polymorphisms with susceptibility to rheumatoid arthritis
Young Ock Kim et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity
Ying Liu et al.
CLINICAL IMMUNOLOGY (2010)
T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells
Rosemarie H. DeKruyff et al.
JOURNAL OF IMMUNOLOGY (2010)
CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch
Holger Hoff et al.
MOLECULAR IMMUNOLOGY (2010)
Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases
Amit K. Maiti et al.
RHEUMATOLOGY (2010)
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation
Guifang Cai et al.
IMMUNOLOGICAL REVIEWS (2009)
The costimulatory role of TIM molecules
Roselynn Rodriguez-Manzanet et al.
IMMUNOLOGICAL REVIEWS (2009)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
Fabian Flores-Borja et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface
Erhu Cao et al.
IMMUNITY (2007)
Association of a BTLA gene polymorphism with the risk of rheumatoid arthritis
Shih-Chang Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator
JR Sedy et al.
NATURE IMMUNOLOGY (2005)
Structural and functional analysis of the costimulatory receptor programmed death-1
XW Zhang et al.
IMMUNITY (2004)
Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus
SC Lin et al.
ARTHRITIS AND RHEUMATISM (2004)
The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis
SC Chae et al.
IMMUNOLOGY LETTERS (2004)
Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope
L Prokunina et al.
ARTHRITIS AND RHEUMATISM (2004)
An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells
L Vijayakrishnan et al.
IMMUNITY (2004)
Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2
M Gavrieli et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
JM Kremer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
L Monney et al.
NATURE (2002)
Assembly and annotation of human chromosome 2q33 sequence cluster containing the CD28, CTLA4, arid ICOS gene cluster:: Analysis by computational, comparative, and microarray approaches
V Ling et al.
GENOMICS (2001)
T-cell regulation by CD28 and CTLA-4
ML Alegre et al.
NATURE REVIEWS IMMUNOLOGY (2001)
Structural basis for co-stimulation by the human CTLA-4/B7-2 complex
JCD Schwartz et al.
NATURE (2001)
Share Paper
